Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.12 AUD | +1.36% |
|
+12.00% | +261.29% |
07-02 | Mesoblast to File Biological License Application with US FDA for Cellular Therapy | MT |
07-01 | Mesoblast to File Biologics License Application for Ryoncil | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+261.29% | 851M | |
+18.01% | 45.34B | |
+42.27% | 40.42B | |
-10.30% | 37.92B | |
+31.17% | 31.75B | |
-7.79% | 27.71B | |
+12.39% | 26.52B | |
+43.36% | 13.96B | |
+30.87% | 12.44B | |
-6.44% | 11.26B |
- Stock Market
- Equities
- MSB Stock
- News Mesoblast Limited
- Piper Sandler Downgrades Mesoblast to Neutral From Overweight, Adjusts Price Target to $2 From $7